Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Intrinsic Hepcidin IDx™ Test to Detect Iron Deficiency and Predict Response to Oral Iron Therapy in Adolescents and Young Adults

NCT03310736 is registered in ClinicalTrials.gov with Intrinsic LifeSciences, LLC as lead sponsor.

NCT NCT03310736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03310736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Intrinsic Hepcidin IDx™ Test to Detect Iron Deficiency and Predict Response to Oral Iron Therapy in Adolescents and Young Adults
Lead sponsor
Intrinsic LifeSciences, LLC
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
February 28, 2019
Enrollment
494 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron deficiency